amobarbital has been researched along with Chronic Disease in 10 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kraines, SH | 1 |
| Schaffer, SW | 1 |
| Croft, CB | 1 |
| Solodushko, V | 1 |
| Shoichet, RP | 1 |
| Bond, AJ | 2 |
| James, DC | 2 |
| Lader, MH | 2 |
| Holmes, B | 1 |
| Good, RA | 1 |
| Kales, A | 1 |
| Bixler, EO | 1 |
| Tan, TL | 1 |
| Scharf, MB | 1 |
| Kales, JD | 1 |
| Mawer, GE | 1 |
| Miller, NE | 2 |
| Turnberg, LA | 2 |
| Huff, JE | 1 |
| Shaw, SM | 1 |
| Christian, JE | 1 |
| Mawer, GW | 1 |
2 trials available for amobarbital and Chronic Disease
| Article | Year |
|---|---|
Sedative effects on physiological and psychological measures in anxious patients.
Topics: Amobarbital; Anti-Anxiety Agents; Anxiety; Auditory Perception; Chlordiazepoxide; Chronic Disease; C | 1974 |
Clinical comparison of anxiolytic drug therapy.
Topics: Administration, Oral; Adolescent; Adult; Amobarbital; Anti-Anxiety Agents; Anxiety; Barbiturates; Ca | 1974 |
8 other studies available for amobarbital and Chronic Disease
| Article | Year |
|---|---|
Therapy of the chronic depressions.
Topics: Alcoholism; Amobarbital; Anorexia Nervosa; Antidepressive Agents; Chronic Disease; Convulsive Therap | 1967 |
Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis.
Topics: Amobarbital; Animals; Apoptosis; bcl-Associated Death Protein; Calcium; Carrier Proteins; Chronic Di | 2000 |
Sodium amytal in the diagnosis of chronic pain.
Topics: Adult; Amobarbital; Chronic Disease; Female; Humans; Infusions, Parenteral; Male; Malingering; Middl | 1978 |
Laboratory models of chronic granulomatous disease.
Topics: Amobarbital; Animals; Blood Bactericidal Activity; Chronic Disease; Dehydroepiandrosterone; Dihydrol | 1972 |
Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependence.
Topics: Adult; Age Factors; Aged; Amobarbital; Chloral Hydrate; Chronic Disease; Dreams; Drug Therapy, Combi | 1974 |
Metabolism of amylobarbitone in patients with chronic liver disease.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Amobarbital; Barbiturates; Bilirubin; Chronic Dis | 1972 |
Effect of acute and chronic stress on amobarbital metabolism in the rat.
Topics: Acute Disease; Amobarbital; Animals; Carbon Isotopes; Chronic Disease; Feces; Male; Rats; Spectropho | 1970 |
Preliminary observations on the elimination of amylobarbitone by patients with chronic liver disease.
Topics: Adult; Amobarbital; Chronic Disease; Humans | 1970 |